Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courau

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cell|December 28, 2021
Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J Combes, Bushra Samad, Jessica Tsui, et al.
Research Square|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|January 25, 2021
Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cell|December 28, 2021
Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J Combes, Bushra Samad, Jessica Tsui, et al.
Research Square|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|January 25, 2021
Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Pageof 5